Vin Menon
CIK: 0002099463
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
APUS
Apimeds Pharmaceuticals US, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Menon Vin
Menon Vin (SEC CIK 0002099463) files insider reports with the SEC as Co-Chief Executive Officer of Apimeds Pharmaceuticals US, Inc. (APUS).
Signal8 holds 1 ownership filing by Menon Vin, a Form 3, filed on Nov 2, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Menon Vin's filings is in NEW YORK, NY.
Other insiders filing for Apimeds Pharmaceuticals US, Inc. (APUS)
- Sherb Eric Michael, Chief Financial Officer
- Inscobee Inc., 10% Owner
- Weintraub Bennett, Director
- Yoon Hankil, Director
- Koo Jakap, Director
- O'DONNELL CAROL A, Director